Of note, a growing body of evidence suggests that Drp1-mediated mitochondrial fission is closely associated with tumorigenesis such as hepatocellular carcinoma, colon cancer, lung cancer, and glioblastoma, acting as a promising therapeutic target for treating cancer [7–9]. Here, DNM1L is linked to lung cancer.